WORLDWIDE‑CORRUPTION

Ecuador · Findings · Debarred / sanctioned abroad × US SEC issuer

GSK · SUB~ · EC · ISSFA

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE ONE I ~0.87' «GLAXOSMITHKLINE ECUADOR S A» ↔ SEC GSK (CIK 1131399, GSK plc): 2 non-competitive contracts at the buyer «ISSFA», 77,787 USD (≈ $77,787); one bid, method direct (Catálogo electrónico - Compra directa en el convenio SICM-366-2022-A, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA INCORPORACIÓN DE MEDICAMENTO; OCID ocds-5wno2w-RE-ISSFA-2021-004-2803, ocds-5wno2w-CE-20250002903977-2803.

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject
GSK · SUB~ · EC · ISSFA
Indicator
Debarred / sanctioned abroad × US SEC issuer
Amount
77,787
Records behind the indicator
2
Found
4 October 2026
Code
W-02850
Reference
SICM-366-2022-A
Reference
ocds-5wno2w-RE-ISSFA-2021-004-2803
Reference
ocds-5wno2w-CE-20250002903977-2803

JSONFindings · Debarred / sanctioned abroad × US SEC issuer